2-<<(N,N-Dimethylamino)methylene>amino>-6-methyl-5-nitro-4(3H)-oxo-3-<(pivaloyloxy)methyl>pyrimidine | 151587-55-2

• 分子结构分类: 有机化合物 - 有机1,3-偶极化合物 - 烯丙基型1,3-偶极有机化合物
• 英文名称: 2-<<(N,N-Dimethylamino)methylene>amino>-6-methyl-5-nitro-4(3H)-oxo-3-<(pivaloyloxy)methyl>pyrimidine
• 英文别名: 2-[(Dimethylamino)methylene]amino-3N-(pivaloyloxy)methyl-6-methyl-5-nitro-4-pyrimidinol；[2-(dimethylaminomethylideneamino)-4-methyl-5-nitro-6-oxopyrimidin-1-yl]methyl 2,2-dimethylpropanoate
• CAS: 151587-55-2
• 化学式: C₁₄H₂₁N₅O₅
• 分子量: 339.351
• InChiKey: WCRMYFNDXINBJK-UHFFFAOYSA-N

物化性质

• 溶解度：
  可溶于二氯甲烷、乙酸乙酯

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  120
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-<<(N,N-Dimethylamino)methylene>amino>-6-methyl-5-nitro-4(3H)-oxo-3-<(pivaloyloxy)methyl>pyrimidine 在 sodium hydroxide 、 sodium dithionite 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 109.0h， 生成 2-氨基-3,5-二氢吡咯并[3,2-D]嘧啶-4-酮
  参考文献：
  名称：

  Pyrrolo[3,2-d]pyrimidine Folate Analogs: "Inverted" Analogs of the Cytotoxic Agent LY231514

  摘要：

  N-{4-[2-(2-Amino-4(3H)-oxo-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]benzoyl}-L-glutamic acid (3a) and N-{4-[3-(2-amino-4(3H)-oxo-5h-pyrrolo[3,2-d]pyrimidin-5-yl)propyl]benzoyl}-L-glutamic acid (3b) were synthesized as potential anticancer agents.

  DOI：

  10.1021/jo00129a040
• 作为产物：
  描述：

  2-氨基-6-甲基-5-硝基-3H-嘧啶-4-酮 在 sodium hydride 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 生成 2-<<(N,N-Dimethylamino)methylene>amino>-6-methyl-5-nitro-4(3H)-oxo-3-<(pivaloyloxy)methyl>pyrimidine
  参考文献：
  名称：

  An expeditious synthesis of 2-amino-4(3)-oxo-5-pyrrolo[3,2-]pyrimidine (9-Deazaguanine)

  摘要：

  9-Deazaguanine has been synthesized in five steps from 2-amino-6-methyl-5-nitro-4(3H)-pyrimidinone by a modification of the Batcho-Leimgruber indole synthesis.

  DOI：

  10.1016/s0040-4039(00)60633-0

文献信息

• Process for preparing 2-pyrrolidinyl-1H-pyrrolo&lsqb;3,2-d&rsqb;pyrimidine inhibitors of nucleoside metabolism
  申请人：Industrial Research Limited

  公开号：US06693193B1

  公开（公告）日：2004-02-17

  A process of preparing a compound of the formula (I) wherein B is chosen from OH, NH2, NHR, H or halogen; D is chosen from OH, NH2, NHR, H halogen or SCH3; R is an optionally substituted alkyl, aralkyl or aryl group; and Z is selected from OH, hydrogen, halogen, hydroxy, SQ or OQ, Q is an optionally substituted all, aralkyl or aryl group; or a tautomer thereof; or a pharmaceutically acceptable salt thereof; or an ester thereof; or a prodrug thereof, which comprises reacting a compound of the formula (II)  with an anion produced by abstraction of the bromine or iodine atom from a compound of formula (XIX),  to form a compound of formula (XX) The compound of formula (XX) is N- and O-deprotected to obtain the compound of formula (I).

  将公式（I）的化合物制备过程翻译成中文： 其中B选择自OH、NH2、NHR、H或卤素；D选择自OH、NH2、NHR、H、卤素或SCH3；R是可选择取代的烷基、芳基烷基或芳基；Z选择自OH、氢、卤素、羟基、SQ或OQ，Q是可选择取代的烷基、芳基烷基或芳基；或其互变异构体；或其药学上可接受的盐；或其酯；或其前药，包括将公式（II）的化合物与通过从公式（XIX）的化合物中提取溴或碘原子而产生的负离子反应，形成公式（XX）的化合物。公式（XX）的化合物经N-和O去保护得到公式（I）的化合物。
• An expeditious synthesis of 2-amino-4(3)-oxo-5-pyrrolo[3,2-]pyrimidine (9-Deazaguanine)
  作者：Edward C. Taylor、Wendy B. Young、Cary C. Ward

  DOI：10.1016/s0040-4039(00)60633-0

  日期：1993.9

  9-Deazaguanine has been synthesized in five steps from 2-amino-6-methyl-5-nitro-4(3H)-pyrimidinone by a modification of the Batcho-Leimgruber indole synthesis.
• Pyrrolo[3,2-d]pyrimidine Folate Analogs: "Inverted" Analogs of the Cytotoxic Agent LY231514
  作者：Edward C. Taylor、Wendy B. Young

  DOI：10.1021/jo00129a040

  日期：1995.12

  N-4-[2-(2-Amino-4(3H)-oxo-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]benzoyl}-L-glutamic acid (3a) and N-4-[3-(2-amino-4(3H)-oxo-5h-pyrrolo[3,2-d]pyrimidin-5-yl)propyl]benzoyl}-L-glutamic acid (3b) were synthesized as potential anticancer agents.